JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 13,620
+140 (1.04%)
Feb 20, 2026, 3:30 PM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 210.9 billion as of February 20, 2026. Its market cap has increased by 29.47% in one year.
Market Cap
210.90B
Enterprise Value
233.95B
Revenue
248.30B
Ranking
n/a
PE Ratio
4.43
Stock Price
13,620.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 210.90B, a decrease of -37.98%. That is a compound annual growth rate of -4.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 210.90B | 5.99% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 240.37B |
| Samil Pharmaceutical Co.,Ltd | 235.44B |
| HLB Pharmaceutical | 234.08B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| AptaBio Therapeutics | 224.75B |
| Jeil Pharmaceutical Co.,Ltd | 213.91B |
| REYON Pharmaceutical | 209.09B |
| SAMSUNG PHARM. Co., LTD. | 204.24B |